Peter Island Ultimate Sheer Dry Touch Sunscreen

Product NDC: 50390-707
11-digit product format: 503900707
Labeler code: 50390
Product ID: 50390-707_1426a253-7c87-489d-95da-1e078f3c9fab
Type: HUMAN OTC DRUG
Nonproprietary name: HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE
Dosage form: LOTION
Route: TOPICAL
Labeler: AMWAY CORP.
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2012-11-26
Marketing end: 0000-00-00
Substance: HOMOSALATE; OXYBENZONE; AVOBENZONE; OCTISALATE; OCTOCRYLENE
Active strength: 15 g/100g; g/100g; g/100g; g/100g; g/100g
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50390-707		I	Inactivated by FDA		2026-10-20
excluded package	package	50390-707	50390-707-12	I	Inactivated by FDA		2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50390-707-12	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50390-707-12	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50390-707-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50390-707-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50390-707-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50390-707-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50390-707-12	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50390-707-12	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50390-707-12	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50390-707-12	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50390-707-12	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50390-707-12	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50390-707-12	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50390-707-12	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50390-707-12	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	50390-707-12	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	50390-707-12	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	50390-707-12	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	50390-707-12	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	50390-707-12	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	50390-707-12	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	50390-707-12	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50390-707-12	2020-01-31	C162847	48780-1	9d75b9d0-0eec-f424-e053-dadaa90a57ce	b7adcec4-7326-49a5-8b23-7f64bc192932

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50390-707-12	Peter Island Ultimate Sheer Dry Touch SunscreenSPF 70	85 g in 1 BOTTLE, PLASTIC	LOTION	85		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
HOMOSALATE	ACTIVE INGREDIENT	V06SV4M95S	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
OXYBENZONE	ACTIVE INGREDIENT	95OOS7VE0Y	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
HOMOSALATE	ACTIVE MOIETY	V06SV4M95S	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
OXYBENZONE	ACTIVE MOIETY	95OOS7VE0Y	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
BUTYLOCTYL SALICYLATE	INACTIVE INGREDIENT	2EH13UN8D3	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
CAPRYLYL TRISILOXANE	INACTIVE INGREDIENT	Q95M2P1KJL	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
CHLORPHENESIN	INACTIVE INGREDIENT	I670DAL4SZ	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
ETHYLHEXYL STEARATE	INACTIVE INGREDIENT	EG3PA2K3K5	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
GLYCYRRHIZINATE DIPOTASSIUM	INACTIVE INGREDIENT	CA2Y0FE3FX	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
TETRASILANE	INACTIVE INGREDIENT	OI9DXJ0BL4	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
TRIDECETH-6	INACTIVE INGREDIENT	3T5PCR2H0C	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3
YELLOW WAX	INACTIVE INGREDIENT	2ZA36H0S2V	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50390-707	PETER ISLAND ULTIMATE SHEER DRY TOUCH SUNSCREEN SPF 70 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) LOTION [AMWAY CORP.]	3	Legacy NDC, 1 package rows	20121128_b7adcec4-7326-49a5-8b23-7f64bc192932.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V06SV4M95S	HOMOSALATE	118-56-9	HOMOSALATE
95OOS7VE0Y	OXYBENZONE	131-57-7	OXYBENZONE
G63QQF2NOX	AVOBENZONE	70356-09-1	AVOBENZONE
4X49Y0596W	OCTISALATE	118-60-5	OCTISALATE
5A68WGF6WM	OCTOCRYLENE	6197-30-4	OCTOCRYLENE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
50390-707-12	50390070712	85 g in 1 BOTTLE, PLASTIC	85 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Peter Island Ultimate Sheer Dry Touch Sunscreen SPF 70 - AMWAY CORP.	AMWAY CORP.	2012-11-26	HUMAN OTC DRUG LABEL	3